Latest News
December 20, 2017
Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients with Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease
December 20, 2017
TARIS and Bristol-Myers Squibb Announce Clinical Trial Collaboration
December 19, 2017
Bristol-Myers Squibb to Announce Results for Fourth Quarter 2017 on February 5th
Latest Events
Event year list
2019
2018
2017
2016
2015
2014
2013
2012
December 6, 2017
02:55 PM ET
Citi 2017 Global Healthcare Conference
November 29, 2017
11:45 AM ET
2017 Evercore ISI Biopharma Catalyst/Deep Dive Conference
November 15, 2017
10:40 AM GMT
Jefferies 2017 London Healthcare Conference